Skip to main content

Zoetis Inc.

ZTS
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001555280

No open-market purchases or sales by Zoetis Inc. insiders were filed in the last 90 days; 1,433 institutions reported holding it in 13F filings for Q2 2026, worth $28.6B in total; superinvestors Markel Group and Soros Fund Management hold it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Zoetis Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Zoetis Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Zoetis Inc.
NameTitleLast reported holdingLast filingFilings, past year
Stetter MarkDirector1,572Sep 18, 20265
Saccaro JamesEVP, CFO & COO–Sep 2, 20261
Damelio Frank ADirector14,808Aug 11, 20264
Sarbaugh KeithExecutive Vice President3,346Jul 14, 20269
Peck Kristin CChief Executive Officer105,068Jul 14, 20269
Nayak Abhay UExecutive Vice President1,965Jul 14, 20261
Esch KevinExecutive Vice President578Jul 14, 20268
Driscoll RimmaExecutive Vice President5,715Jul 14, 20268
Fuller JulieExecutive Vice President1,063Jul 14, 20268
Lagano RoxanneExecutive Vice President15,632Jul 14, 20268
Ferran Astorga JeannetteExecutive Vice President1,684Jul 14, 20266
Joseph WettenyChief Financial Officer22,113Jul 14, 20268
McCallister Michael BDirector0Jun 11, 20264
Parent Louise MDirector28,394May 21, 20263
Bisaro PaulDirector27,862May 13, 20263
Norden GregoryDirector0Mar 10, 20263
Sanjay KhoslaDirector–Feb 23, 20262
Hattersley GavinDirector3,354Feb 23, 20262
Reed Willie MDirector12,864Feb 23, 20262
Leatherberry Antoinette ReneeDirector5,280Feb 23, 20262
Broadhurst VanessaDirector3,920Feb 23, 20262
Ashton NicholasExecutive Vice President1,822Feb 23, 20263
Brannan JamieExecutive Vice President3,290Feb 23, 20263
Tilenius StephanieDirector–Feb 19, 20262
Polzer Robert JExecutive Vice President5,120Oct 14, 20251
Scully Robert WDirector21,489May 23, 20250
Mamilli WafaaExecutive Vice President6,685Oct 8, 20240
Banque Soria EsterExecutive Vice President588Oct 8, 20240
Rhodes LindaDirector11,192May 22, 20240
Chen Heidi C.Executive Vice President31,293Apr 9, 20240
David GlennExecutive Vice President46,572Jan 18, 20230
Bettington Timothy JExecutive Vice President–Oct 11, 20220
Trawicki RomanExecutive Vice President8,218Mar 18, 20220
Knupp Catherine A.Executive Vice President43,642Nov 12, 20210
Pudloski Sherry NExecutive Vice President–Oct 12, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 11, 2025 (view filing)Mar 101 dayLagano RoxanneExecutive Vice PresidentSSale−326$170.00−$55.4K−2.0%15.8K after10b5-1
Jun 4, 2025 (view filing)Jun 31 dayLagano RoxanneExecutive Vice PresidentSSale−652$170.00−$110.8K−4.1%15.1K after10b5-1
Feb 17, 2026 (view filing)Feb 17Same dayPeck Kristin CChief Executive OfficerSSale−20.0K$127.05−$2.54M−16.5%101.3K after2 lots10b5-1
May 12, 2026 (view filing)May 111 dayMcCallister Michael BDirectorPPurchase+3.00K$77.76+$233.3K+13.9%24.5K after
May 13, 2026 (view filing)May 13Same dayBisaro PaulDirectorPPurchase+2.00K$75.88+$151.8K+7.7%27.9K after
May 13, 2026 (view filing)May 13Same dayDamelio Frank ADirectorPPurchase+6.65K$75.39+$501.3K+44.9%21.5K after